< Back | |
17 Nov 2015 | |
The Exchange has sought clarification from Dishman Pharmaceuticals and Chemicals Ltd with reference to the news reported on <BR> moneycontrol on 17/11/2015) - "USFDA gives Warning Letter to Dishman due to Clovis issues".<BR> <BR>The reply is awaited.<BR> | |
View all announcements for DISHMAN PHARMACEUTICALS & CHEMICALS LTD. | Source: BSE India |